Capital is flocking to a few high-growth AI plays and ignoring other opportunities because of the AI trend in the markets.

Neurology biotech Voyager Therapeutics has laid off 30 employees, a spokesperson for the Massachusetts-based company ...

Novartis has discontinued two undisclosed programs under its current partership with Voyager, the biotech announced last month. Projects under the deal for spinal muscular atrophy and Huntington’s ...

Next-generation biologics, such as bispecifics, fusion proteins, and multi-specifics, have multiple functionalities that ...

Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024. Novartis ...

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricingAdditional Novartis medicines will be made available through direct-to-patient platforms in 2026Company ...

Pfizer Inc., AstraZeneca Plc and other companies have struck deals with the Trump administration in recent months ...

U.S. President Donald ​Trump ⁠in July sent letters to 17 drugmakers urging them to slash prices. Pfizer and AstraZeneca first ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...

U.S. President Donald Trump and nine major pharmaceutical companies on Friday announced deals that will slash the prices of their medicines for the government's Medicaid program and for cash payers, ...